{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:11:48Z","timestamp":1794557508053,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00820-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:05:35Z","timestamp":1764331535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HIV vertical transmission linked to virological failure in pregnant women on ART"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-2245","authenticated-orcid":false,"given":"Zenebe","family":"Minda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4542-2509","authenticated-orcid":false,"given":"Lemessa","family":"Oljira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"820_CR1","unstructured":"Centers for Disease Control and Prevention. Preventing Perinatal Transmission of HIV. 2023. https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/preve-perinatal-transmis-hiv. Accessed 24 Mar 2025."},{"key":"820_CR2","unstructured":"World Health Organization. Key Facts on HIV\/AIDS. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids. Accessed 24 Mar 2025."},{"issue":"4","key":"820_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/cid\/ciw792","volume":"64","author":"L Myer","year":"2017","unstructured":"Myer L, Dunning L, Lesosky M, Hsiao NY, Philips T, Petro G, et al. Frequency of viremic episodes in HIV-infected women initiating ART Antiretroviral Therapy during pregnancy. Clin Infect Dis. 2017;64(4):422\u20137. https:\/\/doi.org\/10.1093\/cid\/ciw792.","journal-title":"Clin Infect Dis"},{"key":"820_CR4","unstructured":"The Joint United Nations Programme on HIV\/AIDS. Global Epidemic of HIV. 2019. https:\/\/www.unaids.org\/sit\/media_asset\/2019-UNAIDS-data_en.pdf. Accessed 24 Mar 2025."},{"issue":"1","key":"820_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/2331205X.2019.1623754","volume":"6","author":"AK Tsehay","year":"2019","unstructured":"Tsehay AK. Factors associated with HIV-positive sero-status among exposed infants attending care at health facilities in Bahir Dar administration, Ethiopia: evidence from medical records. Cogent Med. 2019;6(1):623754. https:\/\/doi.org\/10.1080\/2331205X.2019.1623754.","journal-title":"Cogent Med"},{"key":"820_CR6","unstructured":"World Health Organization. Guidance on vertical transmission prevention strategies: where are we? 2024. https:\/\/-guidance-on-vertical-transmission-prevention-strategies.pdf. Accessed 24 Mar 2025."},{"issue":"48","key":"820_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s41182-020-00273-0","volume":"2020","author":"B Amare","year":"2020","unstructured":"Amare B, Tilahun T, Gizat AM. Prevalence of vertical HIV infection and its risk factors among HIV exposed infants in East Africa: a systematic review and meta-analysis. Tropical Med Health. 2020;2020(48):85. https:\/\/doi.org\/10.1186\/s41182-020-00273-0.","journal-title":"Tropical Med Health"},{"key":"820_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/HIV.S277461","volume":"12","author":"GS Teshome","year":"2020","unstructured":"Teshome GS, Modiba LM. Strategies to eliminate MTCT of HIV in Addis Ababa, Ethiopia. HIV\/AIDS-Res Palliat Care. 2020;12:821\u201337. https:\/\/doi.org\/10.2147\/HIV.S277461.","journal-title":"HIV\/AIDS-Res Palliat Care"},{"issue":"Suppl","key":"820_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25000","volume":"7","author":"M Lesosky","year":"2017","unstructured":"Lesosky M, Glass T, Mukonda E, Hsiao NY, Abrams EJ, Myer L. Optimal timing of VL monitoring during pregnancy to predict viraemia at delivery in HIV-1 infected women initiating ART in South Africa: a simulation study. J Int AIDS Soc. 2017;7(Suppl):e25000. https:\/\/doi.org\/10.1002\/jia2.25000.","journal-title":"J Int AIDS Soc"},{"key":"820_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9247451","author":"SY Lokpo","year":"2020","unstructured":"Lokpo SY, Ofori-attah PJ, Amekel LS, Obirhorang C, Orise VN, Kpene GE, et al. Viral suppression and its associated factors in HIV patients on HAART. Hindawi AIDS Res Treat. 2020. https:\/\/doi.org\/10.1155\/2020\/9247451.","journal-title":"Hindawi AIDS Res Treat"},{"key":"820_CR11","unstructured":"Centers for disease control and prevention. HIV treatment as prevention. Overview. 2021. https:\/\/www.cdc.gov\/hiv\/risk\/art\/index.html. Accessed 24 Mar 2025."},{"issue":"12","key":"820_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2147\/HIV.S283917","volume":"7","author":"G Diress","year":"2021","unstructured":"Diress G, Linger M. Change in viral load count and its predictors among unsuppressed VL patients receiving an enhanced adherence counselling intervention at three hospitals in northern Ethiopia. HIV\/AIDS-Res Palliat Care. 2021;7(12):869\u201377. https:\/\/doi.org\/10.2147\/HIV.S283917.","journal-title":"HIV\/AIDS-Res Palliat Care"},{"issue":"11","key":"820_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/cid\/civ578","volume":"61","author":"L Mandelbrot","year":"2015","unstructured":"Mandelbrot L, Tubiana R, Chenadec JL, Dollfus C, FayePannier A, et al. No perinatal HIV-1 transmission from women with effective ART starting before conception. Clin Infect Dis. 2015;61(11):1715\u201325. https:\/\/doi.org\/10.1093\/cid\/civ578.","journal-title":"Clin Infect Dis"},{"key":"820_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2147\/HIV.S221409","volume":"11","author":"YA Yitayew","year":"2019","unstructured":"Yitayew YA, Bekele DM, Demissie BW, Menji ZA. Mother to child transmission of HIV and associated factors among HIV exposed infants at public health facilities, Dessie town, Ethiopia. HIV\/AIDS Res Palliat Care. 2019;11:343\u201350. https:\/\/doi.org\/10.2147\/HIV.S221409.","journal-title":"HIV\/AIDS Res Palliat Care"},{"issue":"8","key":"820_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002375","volume":"14","author":"L Myer","year":"2017","unstructured":"Myer L, Essajee S, Broyles LN, Watts DH, Lesosky M, El-Sadr WM, et al. Pregnant and breastfeeding women: a priority population for HIV viral load monitoring. PLoS Med. 2017;14(8):e1002375. https:\/\/doi.org\/10.1371\/journal.pmed.1002375.","journal-title":"PLoS Med"},{"key":"820_CR16","unstructured":"World Population Review. HIV Rates by Country. 2025. https:\/\/worldpopulationreview.com\/country-rankings\/hiv-rates-by-country. Accessed 25 Mar 2025."},{"issue":"6","key":"820_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198438","volume":"13","author":"AH Mirkuzie","year":"2018","unstructured":"Mirkuzie AH. Implementation and outcomes of guideline revisions for the prevention of mother-to-child HIV transmission in mother support programme, Addis Ababa, Ethiopia. PLoSONE. 2018;13(6):e0198438. https:\/\/doi.org\/10.1371\/journal.pone.0198438.","journal-title":"PLoSONE"},{"key":"820_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20761-w","author":"A Gedefaw","year":"2024","unstructured":"Gedefaw A, Tadesse BT, Tadesse S, Kebede B, Hussen S, Hailu D, et al. The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia. BMC Public Health. 2024. https:\/\/doi.org\/10.1186\/s12889-024-20761-w.","journal-title":"BMC Public Health"},{"key":"820_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/IDR.S341392","volume":"15","author":"GT Atnafu","year":"2022","unstructured":"Atnafu GT, Moges NA, Wubie M, Gedif G. Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infect Drug Resist. 2022;15:261\u201374. https:\/\/doi.org\/10.2147\/IDR.S341392.","journal-title":"Infect Drug Resist"},{"key":"820_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3262746","author":"W Fisseha","year":"2016","unstructured":"Fisseha W, Damtew B. Mother-to-child transmission of HIV infection and its determinants among exposed infants on care and follow-up in Dire Dawa city, Eastern Ethiopia. AIDS Res Treat. 2016. https:\/\/doi.org\/10.1155\/2016\/3262746.","journal-title":"AIDS Res Treat"},{"key":"820_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1186\/s12879-024-10002-1","volume":"24","author":"AA Berhane","year":"2024","unstructured":"Berhane AA, Chimdesa HF, Awedew AF, et al. Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia. BMC Infect Dis. 2024;24:1068. https:\/\/doi.org\/10.1186\/s12879-024-10002-1.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"820_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-015-0120-1","volume":"16","author":"W Teshome","year":"2015","unstructured":"Teshome W, Tefera A. Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. BMC Immunol. 2015;16(1):1\u20137. https:\/\/doi.org\/10.1186\/s12865-015-0120-1.","journal-title":"BMC Immunol"},{"issue":"1","key":"820_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1186\/s12879-019-4702-z","volume":"19","author":"JH Ali","year":"2018","unstructured":"Ali JH, Yirtaw TG. Time to viral load suppression and its associated factors in a cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia. BMC Infect Dis. 2018;19(1):1084. https:\/\/doi.org\/10.1186\/s12879-019-4702-z.","journal-title":"BMC Infect Dis"},{"key":"820_CR24","unstructured":"World Health Organization. National consolidated guidelines for comprehensive HIV prevention, care and treatment. 2019. https:\/\/www.afro.who.int\/publications\/national-consolidated-guidelines-comprehensive-hiv-prevention-care-and-treatment. Accessed 27 Mar 2025."},{"issue":"6","key":"820_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0956462417748859","volume":"29","author":"DJ Davey","year":"2018","unstructured":"Davey DJ, Abrahams Z, Feinberg M, Prins M, Serrao C, Medeossi B, et al. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line ART in South Africa. Int J STD AIDS. 2018;29(6):603\u201310. https:\/\/doi.org\/10.1177\/0956462417748859.","journal-title":"Int J STD AIDS"},{"key":"820_CR26","unstructured":"World Health Organization. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240039360. Accessed 28 Mar 2025."},{"issue":"5","key":"820_CR27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029058","volume":"146","author":"EG Chadwick","year":"2020","unstructured":"Chadwick EG, Ezeanolue EE, Aids COP, Hsui KKC, Kourtis AP, Mirza A, et al. Evaluation and Management of the Infant Exposed to HIV in the United States. Pediatrics. 2020;146(5):e2020029058. https:\/\/doi.org\/10.1542\/peds.2020-029058.","journal-title":"Pediatrics"},{"key":"820_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12981-025-00701-3","volume":"22","author":"I Nankya","year":"2025","unstructured":"Nankya I, Natukunda E, Rutebarika D, Matama C, Basiimwa R, Arikod P, et al. High prevalence of low-level viremia among infants initiated on antiretroviral drugs following VT of HIV. AIDS Res Ther. 2025;22:34. https:\/\/doi.org\/10.1186\/s12981-025-00701-3.","journal-title":"AIDS Res Ther"},{"key":"820_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","volume":"20","author":"S SeyedAlinaghi","year":"2023","unstructured":"SeyedAlinaghi S, Afsahi AM, Moradi A, Parmoon Z, Habibi P, Mirzapour P, et al. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review. AIDS Res Ther. 2023;20:74. https:\/\/doi.org\/10.1186\/s12981-023-00572-6.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"820_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/ciac762","volume":"76","author":"O Elvstam","year":"2023","unstructured":"Elvstam O, Malmborn K, El\u00e9n S, Marrone G, Garc\u00eda F, Zazzi M, et al. Virologic failure following low-level viremia and viral blips during ART: results from a European multicenter cohort. Clin Infect Dis. 2023;76(1):25\u201331. https:\/\/doi.org\/10.1093\/cid\/ciac762.","journal-title":"Clin Infect Dis"},{"key":"820_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12879-021-06162-z","volume":"21","author":"S Qin","year":"2021","unstructured":"Qin S, Lai J, Zhang H, We D, Lv Q, Pan X, et al. Predictive factors of viral load high-risk events for virological failure in HIV\/AIDS patients receiving long-term antiviral therapy. BMC Infect Dis. 2021;21:448. https:\/\/doi.org\/10.1186\/s12879-021-06162-z.","journal-title":"BMC Infect Dis"},{"key":"820_CR32","unstructured":"The United States President\u2019s emergency plan for AIDS relief. Update point-of-care viral load: pregnant and breastfeeding women. 2019. https:\/\/aslm.org\/wp-content\/uploads\/2019\/11\/POC-VL-Presentation_IDC_v4.pdf. Accessed 28 Mar 2025."},{"issue":"5","key":"820_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232358","volume":"15","author":"M Sandbulte","year":"2020","unstructured":"Sandbulte M, Brown M, Wexler C, Maloba M, Gautney B, Goggin K, et al. Maternal viral load monitoring: coverage and clinical action at 4 Kenyan hospitals. PLoS ONE. 2020;15(5):e0232358. https:\/\/doi.org\/10.1371\/journal.pone.0232358.","journal-title":"PLoS ONE"},{"key":"820_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12879-024-09202-6","volume":"24","author":"N Hurbans","year":"2024","unstructured":"Hurbans N, Naidoo P. Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study. BMC Infect Dis. 2024;24:343. https:\/\/doi.org\/10.1186\/s12879-024-09202-6.","journal-title":"BMC Infect Dis"},{"key":"820_CR35","unstructured":"World Health Organization. Update of recommendations on first and second-line antiretroviral regimens. 2019. https:\/\/iris.who.int\/bitstream\/handle\/10665\/325892\/WHO-CDS-HIV-19.15-eng.pdf. Accessed 30 Mar 2025."},{"key":"820_CR36","unstructured":"World Health Organization. HIV drug resistance report. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240038608. Accessed 30 Mar 2025."},{"key":"820_CR37","unstructured":"American college of obstetricians and gynecologists. Labor and delivery management of women with Human Immunodeficiency Virus infection. 2024. https:\/\/www.acog.org\/clini-guida\/committee-opinion\/arti\/2018\/09\/labor-&-delivery-manage. Accessed 30 Mar 2025."},{"key":"820_CR38","unstructured":"Infectious disease. Approach to reducing VT of HIV in pregnancy. 2016. https:\/\/www.infecusdiseasdvisor.com\/slishow\/hiv-aids\/approch-to-reding-vct-of-hiv-in-pregnancy\/. Accessed 30 Mar 2025."},{"issue":"2","key":"820_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229111","volume":"15","author":"D Onoya","year":"2020","unstructured":"Onoya D, Nattey C, Jinga N, Mongwenyana C, Sherman G. Time of HIV diagnosis, CD4 count and viral load at antenatal care start and delivery in South Africa. PLoS ONE. 2020;15(2):e0229111. https:\/\/doi.org\/10.1371\/journal.pone.0229111.","journal-title":"PLoS ONE"},{"issue":"4","key":"820_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195033","volume":"13","author":"MB Chagomerana","year":"2018","unstructured":"Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Mthiko BC, Phulusa J, et al. Optimizing prevention of HIV mother to child transmission: Duration of ART and viral suppression at delivery among pregnant Malawian women. PLoS ONE. 2018;13(4):e0195033. https:\/\/doi.org\/10.1371\/journal.pone.0195033.","journal-title":"PLoS ONE"},{"key":"820_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12887-023-04074-2","volume":"23","author":"G Gutema","year":"2023","unstructured":"Gutema G, Tola HH, Fikadu D, Leta D, Bejiga B, Tura JB, et al. Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants. BMC Pediatr. 2023;23:283. https:\/\/doi.org\/10.1186\/s12887-023-04074-2.","journal-title":"BMC Pediatr"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00820-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:05:37Z","timestamp":1764331537000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00820-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Haramaya University\u2019s Institutional Health Research Ethics Committee. Consent was waived due to the use of secondary data. Confidentiality was maintained in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"127"}}